CHINA PHARMA HOLDINGS, INC. (CPHI) › Total LiabilitiesCHINA PHARMA HOLDINGS, INC. (CPHI) — Total LiabilitiesAnnual figures by period end, from SEC filings.2010-12-31: $13.81M2011-12-31: $13.91M2012-12-31: $14.72M2013-12-31: $24.67M2014-12-31: $28.34M2015-12-31: $23.87M2016-12-31: $19.61M2017-12-31: $16.88M2018-12-31: $15.18M2019-12-31: $13.00M2020-12-31: $13.11M2021-12-31: $16.63M2022-12-31: $13.49M2023-12-31: $9.01M2024-12-31: $7.14M2025-12-31: $8.26M$8.26M2010-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$8.26M+15.7%2026-04-01Balance as of period end2024-12-31$7.14M-20.8%2026-04-01Balance as of period end2023-12-31$9.01M-33.2%2025-03-31Balance as of period end2022-12-31$13.49M-18.9%2024-04-01Balance as of period end2021-12-31$16.63M+26.8%2023-03-30Balance as of period end2020-12-31$13.11M+0.9%2022-03-30Balance as of period end2019-12-31$13.00M-14.4%2021-03-26Balance as of period end2018-12-31$15.18M-10.1%2020-03-30Balance as of period end2017-12-31$16.88M-13.9%2019-03-28Balance as of period end2016-12-31$19.61M-17.9%2018-04-02Balance as of period end2015-12-31$23.87M-15.8%2017-03-31Balance as of period end2014-12-31$28.34M+14.9%2016-03-30Balance as of period end2013-12-31$24.67M+67.5%2015-12-28Balance as of period end2012-12-31$14.72M+5.9%2014-03-20Balance as of period end2011-12-31$13.91M+0.7%2013-03-14Balance as of period end2010-12-31$13.81M—2012-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)